Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raman Bahal

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Molecules (Basel, Switzerland)|June 26, 2020
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene TherapyAniket Wahane, Akaash Waghmode, Alexander Kapphahn, et al.
Plos One|January 1, 2020
Ontogenic mRNA expression of RNA modification writers, erasers, and readers in mouse liverLiming Chen, Pei Wang, Raman Bahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 19, 2016
Nanotechnology for delivery of peptide nucleic acids (PNAs)Anisha Gupta, Raman Bahal, Meera Gupta, et al.
The Yale Journal of Biology and Medicine|December 21, 2017
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and OpportunitiesElias Quijano, Raman Bahal, Adele Ricciardi, et al.
Journal of Nucleic Acids|July 22, 2011
Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAsMatthew J Crawford, Srinivas Rapireddy, Raman Bahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 25, 2020
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticlesShipra Malik, Jihoon Lim, Frank J Slack, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 12, 2024
Efficient and selective kidney targeting by chemically modified carbohydrate conjugatesVikas Kumar, Aniket Wahane, Ming Shen Tham, et al.
Pharmaceuticals (Basel, Switzerland)|August 14, 2020
Emerging Therapeutic Modalities against COVID-19Shipra Malik, Anisha Gupta, Xiaobo Zhong, et al.
Journal of Clinical Medicine|July 2, 2020
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and DevelopmentKarishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Cell Reports. Physical Science|October 18, 2024
Enhancing RNA inhibitory activity using clamp-G-modified nucleobasesSai Pallavi Pradeep, Vikas Kumar, Shipra Malik, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Molecules (Basel, Switzerland)|June 26, 2020
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene TherapyAniket Wahane, Akaash Waghmode, Alexander Kapphahn, et al.
Plos One|January 1, 2020
Ontogenic mRNA expression of RNA modification writers, erasers, and readers in mouse liverLiming Chen, Pei Wang, Raman Bahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 19, 2016
Nanotechnology for delivery of peptide nucleic acids (PNAs)Anisha Gupta, Raman Bahal, Meera Gupta, et al.
The Yale Journal of Biology and Medicine|December 21, 2017
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and OpportunitiesElias Quijano, Raman Bahal, Adele Ricciardi, et al.
Journal of Nucleic Acids|July 22, 2011
Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAsMatthew J Crawford, Srinivas Rapireddy, Raman Bahal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 25, 2020
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticlesShipra Malik, Jihoon Lim, Frank J Slack, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 12, 2024
Efficient and selective kidney targeting by chemically modified carbohydrate conjugatesVikas Kumar, Aniket Wahane, Ming Shen Tham, et al.
Pharmaceuticals (Basel, Switzerland)|August 14, 2020
Emerging Therapeutic Modalities against COVID-19Shipra Malik, Anisha Gupta, Xiaobo Zhong, et al.
Journal of Clinical Medicine|July 2, 2020
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and DevelopmentKarishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Cell Reports. Physical Science|October 18, 2024
Enhancing RNA inhibitory activity using clamp-G-modified nucleobasesSai Pallavi Pradeep, Vikas Kumar, Shipra Malik, et al.
Pageof 8